As previously discussed here, the Centers for Medicare & Medicaid Services (CMS) has proposed a reimbursement pilot program for Part B drugs. Different factions of legislators have asked CMS to reconsider the controversial pilot.
Last week, some members of Congress circulated a draft letter to CMS Acting Administrator Andy Slavitt, expressing their concerns about the reimbursement pilot and asking CMS to consider certain unintended consequences.
In addition, a group of Senate Finance Committee Republicans, led by Chairman Orrin Hatch, sent a letter to Mr. Slavitt with a somewhat simpler description of the perceived problems, and a group of Senate Finance Committee Democrats chimed in with their own letter.
This blog will continue to cover developments related to the pilot program.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
